<?xml version="1.0" encoding="UTF-8"?>
<ref id="cam41388-bib-0004">
 <label>4</label>
 <mixed-citation publication-type="journal" id="cam41388-cit-0004">
  <string-name>
   <surname>Ghidini</surname>, 
   <given-names>M.</given-names>
  </string-name>, 
  <string-name>
   <given-names>J. C.</given-names>
   <surname>Hahne</surname>
  </string-name>, 
  <string-name>
   <given-names>F.</given-names>
   <surname>Trevisani</surname>
  </string-name>, 
  <string-name>
   <given-names>S.</given-names>
   <surname>Panni</surname>
  </string-name>, 
  <string-name>
   <given-names>M.</given-names>
   <surname>Ratti</surname>
  </string-name>, 
  <string-name>
   <given-names>L.</given-names>
   <surname>Toppo</surname>
  </string-name>, et al. 
  <year>2016</year>
  <article-title>New developments in the treatment of chemotherapy‐induced neutropenia: focus on balugrastim</article-title>. 
  <source>Ther. Clin. Risk Manag.</source>
  <volume>12</volume>:
  <fpage>1009</fpage>–
  <lpage>1015</lpage>.
  <pub-id pub-id-type="pmid">27445479</pub-id>
 </mixed-citation>
</ref>
